Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Chromosomes, Human, Pair 1"" wg kryterium: Wszystkie pola


Tytuł:
FSTest: an efficient tool for cross-population fixation index estimation on variant call format files.
Autorzy:
Vahedi SM; Department of Animal Science and Aquaculture, Dalhousie University, Bible Hill, NS B2N5E3, .
Ardestani SS
Pokaż więcej
Źródło:
Journal of genetics [J Genet] 2024; Vol. 103.
Typ publikacji:
Journal Article
MeSH Terms:
Chromosomes, Human, Pair 1*/genetics
Genetics, Population*/methods
Genetics, Population*/statistics & numerical data
South Asian People*/genetics
African People*/genetics
Genetic Variation*/genetics
Humans ; Asian People/genetics ; Biological Evolution ; Genomics ; Genotype
Czasopismo naukowe
Tytuł:
Homozygosity for a Novel DOCK7 Variant Due to Segmental Uniparental Isodisomy of Chromosome 1 Associated with Early Infantile Epileptic Encephalopathy (EIEE) and Cortical Visual Impairment.
Autorzy:
Kivrak Pfiffner F; Institute of Medical Molecular Genetics, University of Zurich, Wagistrasse 12, 8952 Schlieren, Switzerland.
Koller S; Institute of Medical Molecular Genetics, University of Zurich, Wagistrasse 12, 8952 Schlieren, Switzerland.
Ménétrey A; Department of Pediatric Neurology, University Children's Hospital, University of Zurich, 8032 Zurich, Switzerland.
Graf U; Institute of Medical Molecular Genetics, University of Zurich, Wagistrasse 12, 8952 Schlieren, Switzerland.
Bähr L; Institute of Medical Molecular Genetics, University of Zurich, Wagistrasse 12, 8952 Schlieren, Switzerland.
Maspoli A; Institute of Medical Molecular Genetics, University of Zurich, Wagistrasse 12, 8952 Schlieren, Switzerland.
Hackenberg A; Department of Pediatric Neurology, University Children's Hospital, University of Zurich, 8032 Zurich, Switzerland.
Kottke R; Department of Diagnostic Imaging, University Children's Hospital, University of Zurich, 8032 Zurich, Switzerland.
Gerth-Kahlert C; Department of Ophthalmology, University Hospital, 8091 Zurich, Switzerland.
Berger W; Institute of Medical Molecular Genetics, University of Zurich, Wagistrasse 12, 8952 Schlieren, Switzerland.; Neuroscience Center Zurich, University and ETH Zurich, 8057 Zurich, Switzerland.; Center for Integrative Human Physiology, University of Zurich, 8057 Zurich, Switzerland.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 Jul 02; Vol. 23 (13). Date of Electronic Publication: 2022 Jul 02.
Typ publikacji:
Case Reports
MeSH Terms:
Chromosomes, Human, Pair 1*
Uniparental Disomy*
Female ; GTPase-Activating Proteins/genetics ; Guanine Nucleotide Exchange Factors/genetics ; Humans ; Infant ; Polymorphism, Single Nucleotide ; Spasms, Infantile ; Vision Disorders
SCR Disease Name:
Infantile Epileptic-Dyskinetic Encephalopathy
Raport
Tytuł:
Prognostic heterogeneity of adult B-cell precursor acute lymphoblastic leukaemia patients with t(1;19)(q23;p13)/TCF3-PBX1 treated with measurable residual disease-oriented protocols.
Autorzy:
Ribera J; Josep Carreras Leukaemia Research Institute, ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.
Granada I; Josep Carreras Leukaemia Research Institute, ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.
Morgades M; Josep Carreras Leukaemia Research Institute, ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.
González T; Hospital Universitario de Salamanca, Universidad de Salamanca, IBMCC (CSIC/USAL), IBSAL and CIBERONC, Salamanca, Spain.
Ciudad J; Cytometry Service (NUCLEUS) and Department of Medicine, Cancer Research Center (IBMCC-CSIC/USAL-IBSAL), University of Salamanca, Salamanca, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC) CB16/12/00400, Instituto de Salud Carlos III, Madrid, Spain.
Such E; Hematology Department, Hospital Universitari Politècnic La Fe, Valencia, Spain.
Calasanz MJ; Centro de Investigación Clínica Aplicada (CIMA), Universidad de Navarra, Pamplona, Spain.
Mercadal S; Hematology Department, ICO-Hospital Duran i Reynals, Hospitalet de Llobregat, Spain.
Coll R; Hematology Department, ICO-Hospital Josep Trueta, Girona, Spain.
González-Campos J; Hematology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
Tormo M; Hematology Department, Hospital Clínico Universitario, Valencia, Spain.
García-Cadenas I; Hematology Department, Hospital de Sant Pau, Josep Carreras Leukaemia Research Institute, Barcelona, Spain.
Gil C; Hematology Department, Hospital General de Alicante, Alicante, Spain.
Cervera M; Hematology Department, ICO-Hospital Joan XXIII, Tarragona, Spain.
Barba P; Hematology Department, Hospital Universitari Vall d'Hebrón, Barcelona, Spain.
Costa D; Haematopathology Section, Department of Pathology, Hospital Clínic, Barcelona, Spain.
Ayala R; Hematology Department, Hospital Universitario Doce de Octubre, Madrid, Spain.
Bermúdez A; Hematology Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
Orfao A; Cytometry Service (NUCLEUS) and Department of Medicine, Cancer Research Center (IBMCC-CSIC/USAL-IBSAL), University of Salamanca, Salamanca, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC) CB16/12/00400, Instituto de Salud Carlos III, Madrid, Spain.
Ribera JM; Josep Carreras Leukaemia Research Institute, ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.
Pokaż więcej
Corporate Authors:
Programa para el Tratamiento de Hemopatias Malignas (PETHEMA) Group (Spanish Society of Hematology, SEHH)
Źródło:
British journal of haematology [Br J Haematol] 2022 Feb; Vol. 196 (3), pp. 670-675. Date of Electronic Publication: 2021 Sep 21.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Chromosomes, Human, Pair 1*
Chromosomes, Human, Pair 19*
Translocation, Genetic*
Neoplasm, Residual/*therapy
Oncogene Proteins, Fusion/*genetics
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/*genetics
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/*therapy
Adolescent ; Adult ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Chromosome Banding ; Disease Management ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Metastasis ; Neoplasm Staging ; Neoplasm, Residual/diagnosis ; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/diagnosis ; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/mortality ; Prognosis ; Remission Induction ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł:
Outcomes of patients with multiple myeloma harboring chromosome 1q gain/amplification in the era of modern therapy.
Autorzy:
Hu X; Division of Hematology-Oncology, Tufts Medical Center, Boston, MA, 02111, USA.
Wu CH; Department of Medicine, Tufts Medical Center, Boston, MA, 02111, USA.
Cowan JM; Department of Pathology and Laboratory Medicine, Tufts Medical Center, Boston, MA, 02111, USA.
Comenzo RL; Division of Hematology-Oncology, Tufts Medical Center, Boston, MA, 02111, USA.; Tufts Medical Center, The John Conant Davis Myeloma and Amyloid Program, Boston, MA, 02111, USA.
Varga C; Division of Hematology-Oncology, Tufts Medical Center, Boston, MA, 02111, USA. .; Tufts Medical Center, The John Conant Davis Myeloma and Amyloid Program, Boston, MA, 02111, USA. .
Pokaż więcej
Źródło:
Annals of hematology [Ann Hematol] 2022 Feb; Vol. 101 (2), pp. 369-378. Date of Electronic Publication: 2021 Nov 08.
Typ publikacji:
Journal Article
MeSH Terms:
Chromosome Duplication*
Chromosomes, Human, Pair 1*
Multiple Myeloma/*genetics
Aged ; Disease Management ; Female ; Humans ; Male ; Middle Aged ; Multiple Myeloma/epidemiology ; Multiple Myeloma/therapy ; Retrospective Studies ; Survival Analysis
Czasopismo naukowe
Tytuł:
Functional analysis of the 1p34.3 risk locus implicates GNL2 in high-grade serous ovarian cancer.
Autorzy:
Nakamura K; Department of Molecular Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
Reid BM; Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA. Electronic address: .
Chen A; Department of Biostatics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
Chen Z; Department of Biostatics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
Goode EL; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN 55905, USA.
Permuth JB; Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
Teer JK; Department of Biostatics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
Tyrer J; The Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, CB1 8RN, United Kingdom.
Yu X; Department of Biostatics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
Kanetsky PA; Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
Pharoah PD; The Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, CB1 8RN, United Kingdom.
Gayther SA; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Sellers TA; TAS Consulting, Portland, OR, USA.
Lawrenson K; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Karreth FA; Department of Molecular Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA. Electronic address: .
Pokaż więcej
Źródło:
American journal of human genetics [Am J Hum Genet] 2022 Jan 06; Vol. 109 (1), pp. 116-135. Date of Electronic Publication: 2021 Dec 28.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Chromosomes, Human, Pair 1*
Genetic Predisposition to Disease*
Quantitative Trait Loci*
Cystadenocarcinoma, Serous/*genetics
GTP-Binding Proteins/*genetics
Ovarian Neoplasms/*genetics
Alleles ; Alternative Splicing ; Animals ; Cell Line, Tumor ; Cell Transformation, Neoplastic/genetics ; Chromatin Immunoprecipitation Sequencing ; Cystadenocarcinoma, Serous/pathology ; DNA Copy Number Variations ; Disease Models, Animal ; Enhancer Elements, Genetic ; Female ; GTP-Binding Proteins/metabolism ; Gene Expression Profiling ; Gene Expression Regulation, Neoplastic ; Gene Silencing ; Genetic Association Studies ; Genome-Wide Association Study ; Heterografts ; Humans ; Mice ; Neoplasm Grading ; Odds Ratio ; Ovarian Neoplasms/epidemiology ; Ovarian Neoplasms/mortality ; Ovarian Neoplasms/pathology ; Polymorphism, Single Nucleotide ; Prognosis ; Transcriptome ; White People
Czasopismo naukowe
Tytuł:
Usher syndrome type 2A complicated with glycogen storage disease type 3 due to paternal uniparental isodisomy of chromosome 1 in a sporadic patient.
Autorzy:
Wang H; Department of Pediatric Neurology, Shengjing Hospital of China Medical University, Shenyang, P.R. China.
Huo L; Department of Pediatric Neurology, Shengjing Hospital of China Medical University, Shenyang, P.R. China.
Wang Y; Chigene (Beijing) Translational Medical Research Center Co., Ltd., Beijing, P.R. China.
Sun W; Chigene (Beijing) Translational Medical Research Center Co., Ltd., Beijing, P.R. China.
Gu W; Chigene (Beijing) Translational Medical Research Center Co., Ltd., Beijing, P.R. China.
Pokaż więcej
Źródło:
Molecular genetics & genomic medicine [Mol Genet Genomic Med] 2021 Oct; Vol. 9 (10), pp. e1779. Date of Electronic Publication: 2021 Aug 18.
Typ publikacji:
Case Reports; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Chromosomes, Human, Pair 1*
Paternal Inheritance*
Uniparental Disomy*
Glycogen Storage Disease Type III/*complications
Glycogen Storage Disease Type III/*diagnosis
Usher Syndromes/*complications
Usher Syndromes/*diagnosis
Adult ; Biomarkers ; Child, Preschool ; DNA Copy Number Variations ; Female ; Genetic Association Studies ; Genetic Predisposition to Disease ; Glycogen Debranching Enzyme System/chemistry ; Glycogen Debranching Enzyme System/genetics ; Glycogen Storage Disease Type III/etiology ; Glycogen Storage Disease Type III/metabolism ; Humans ; Male ; Middle Aged ; Models, Molecular ; Pedigree ; Sequence Analysis, DNA ; Structure-Activity Relationship ; Usher Syndromes/etiology ; Usher Syndromes/metabolism ; Exome Sequencing
SCR Disease Name:
Usher syndrome, type 2A
Czasopismo naukowe
Tytuł:
Genome collinearity analysis illuminates the evolution of donkey chromosome 1 and horse chromosome 5 in perissodactyls: A comparative study.
Autorzy:
Li S; Research Center for Animal Genetic Resources of Mongolia Plateau, College of Life Sciences, Inner Mongolia University, Hohhot, 010070, China.; College of Basic Medicine, Inner Mongolia Medical University, Hohhot, 010110, China.; Inner Mongolia Saikexing Institute of Breeding and Reproductive Biotechnology in Domestic Animal, Hohhot, 011517, China.
Zhao G; Inner Mongolia Saikexing Institute of Breeding and Reproductive Biotechnology in Domestic Animal, Hohhot, 011517, China.
Han H; Department of Physical Education, Hohhot Minzu College, Hohhot, 010051, China.
Li Y; Research Center for Animal Genetic Resources of Mongolia Plateau, College of Life Sciences, Inner Mongolia University, Hohhot, 010070, China.; Inner Mongolia Saikexing Institute of Breeding and Reproductive Biotechnology in Domestic Animal, Hohhot, 011517, China.
Li J; Inner Mongolia Saikexing Institute of Breeding and Reproductive Biotechnology in Domestic Animal, Hohhot, 011517, China.
Wang J; College of Basic Medicine, Inner Mongolia Medical University, Hohhot, 010110, China.
Cao G; College of Veterinary Science, Inner Mongolia Agricultural University, Hohhot, 010018, China.
Li X; Research Center for Animal Genetic Resources of Mongolia Plateau, College of Life Sciences, Inner Mongolia University, Hohhot, 010070, China. .; Inner Mongolia Saikexing Institute of Breeding and Reproductive Biotechnology in Domestic Animal, Hohhot, 011517, China. .
Pokaż więcej
Źródło:
BMC genomics [BMC Genomics] 2021 Sep 15; Vol. 22 (1), pp. 665. Date of Electronic Publication: 2021 Sep 15.
Typ publikacji:
Journal Article
MeSH Terms:
Chromosomes, Human, Pair 1*
Equidae*/genetics
Animals ; Chromosomes/genetics ; Chromosomes, Human, Pair 5 ; Genome ; Horses/genetics ; Humans
Czasopismo naukowe
Tytuł:
WHO grade I meningiomas that show regrowth after gamma knife radiosurgery often show 1p36 loss.
Autorzy:
Damen PJJ; Department of Pathology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, P. Debyelaan 25, Postbox 5800, 6202 AZ, Maastricht, The Netherlands.
Bulthuis VJ; Department of Neurosurgery, Maastricht University Medical Center, Maastricht, The Netherlands.
Hanssens PEJ; Gamma Knife Center Tilburg, ETZ-Elisabeth Hospital, Tilburg, The Netherlands.
Lie ST; Gamma Knife Center Tilburg, ETZ-Elisabeth Hospital, Tilburg, The Netherlands.
Fleischeuer R; Department of Pathology, ETZ-Elisabeth Hospital, Tilburg, The Netherlands.
Melotte V; Department of Pathology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, P. Debyelaan 25, Postbox 5800, 6202 AZ, Maastricht, The Netherlands.
Wouters KA; Department of Pathology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, P. Debyelaan 25, Postbox 5800, 6202 AZ, Maastricht, The Netherlands.
Ruland A; Department of Pathology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, P. Debyelaan 25, Postbox 5800, 6202 AZ, Maastricht, The Netherlands.
Beckervordersandforth J; Department of Pathology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, P. Debyelaan 25, Postbox 5800, 6202 AZ, Maastricht, The Netherlands.
Speel EJM; Department of Pathology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, P. Debyelaan 25, Postbox 5800, 6202 AZ, Maastricht, The Netherlands. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Aug 12; Vol. 11 (1), pp. 16432. Date of Electronic Publication: 2021 Aug 12.
Typ publikacji:
Journal Article
MeSH Terms:
Chromosome Deletion*
Chromosomes, Human, Pair 1*
Meningeal Neoplasms/*pathology
Meningeal Neoplasms/*radiotherapy
Meningioma/*pathology
Meningioma/*radiotherapy
Neoplasm Recurrence, Local/*pathology
Radiosurgery/*methods
Female ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Survival Rate ; Treatment Outcome ; World Health Organization
Czasopismo naukowe
Tytuł:
Whole-genome optical mapping of bone-marrow myeloma cells reveals association of extramedullary multiple myeloma with chromosome 1 abnormalities.
Autorzy:
Kriegova E; Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Hnevotinska 3, 779 00, Olomouc, Czech Republic. .
Fillerova R; Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Hnevotinska 3, 779 00, Olomouc, Czech Republic.
Minarik J; Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic.
Savara J; Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Hnevotinska 3, 779 00, Olomouc, Czech Republic.; Department of Computer Science, Faculty of Electrical Engineering and Computer Science, VŠB-Technical University of Ostrava, Ostrava, Czech Republic.
Manakova J; Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Hnevotinska 3, 779 00, Olomouc, Czech Republic.
Petrackova A; Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Hnevotinska 3, 779 00, Olomouc, Czech Republic.
Dihel M; Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Hnevotinska 3, 779 00, Olomouc, Czech Republic.
Balcarkova J; Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic.
Krhovska P; Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic.
Pika T; Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic.
Gajdos P; Department of Computer Science, Faculty of Electrical Engineering and Computer Science, VŠB-Technical University of Ostrava, Ostrava, Czech Republic.
Behalek M; Department of Computer Science, Faculty of Electrical Engineering and Computer Science, VŠB-Technical University of Ostrava, Ostrava, Czech Republic.
Vasinek M; Department of Computer Science, Faculty of Electrical Engineering and Computer Science, VŠB-Technical University of Ostrava, Ostrava, Czech Republic.
Papajik T; Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Jul 19; Vol. 11 (1), pp. 14671. Date of Electronic Publication: 2021 Jul 19.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Chromosome Aberrations*
Chromosomes, Human, Pair 1*/genetics
Bone Marrow/*pathology
Multiple Myeloma/*genetics
Aged ; Aged, 80 and over ; Bone Marrow/diagnostic imaging ; Bone Marrow/metabolism ; Bone Marrow Cells/pathology ; Cohort Studies ; Cytogenetic Analysis/methods ; Czech Republic ; Female ; Genome-Wide Association Study/methods ; Humans ; Male ; Middle Aged ; Multiple Myeloma/pathology ; Pilot Projects
Czasopismo naukowe
Tytuł:
Reproductive risks and preimplantation genetic testing intervention for X-autosome translocation carriers.
Autorzy:
Yuan S; Reproductive and Genetic Hospital of CITIC-Xiangya, Changsha Hunan, China; Clinical Research Center For Reproduction and Genetics in Hunan Province, Changsha Hunan, China.
Cheng D; Reproductive and Genetic Hospital of CITIC-Xiangya, Changsha Hunan, China; Clinical Research Center For Reproduction and Genetics in Hunan Province, Changsha Hunan, China.
Luo K; Reproductive and Genetic Hospital of CITIC-Xiangya, Changsha Hunan, China; Clinical Research Center For Reproduction and Genetics in Hunan Province, Changsha Hunan, China.
Li X; Reproductive and Genetic Hospital of CITIC-Xiangya, Changsha Hunan, China; Clinical Research Center For Reproduction and Genetics in Hunan Province, Changsha Hunan, China.
Hu L; Reproductive and Genetic Hospital of CITIC-Xiangya, Changsha Hunan, China; Clinical Research Center For Reproduction and Genetics in Hunan Province, Changsha Hunan, China; Institute of Reproduction and Stem Cell Engineering, School of Basic Medical Science, Central South University, Changsha Hunan, China; National Engineering and Research Center of Human Stem Cells, Changsha Hunan, China; HC Key Laboratory of Human Stem Cell and Reproductive Engineering (Central South University), Changsha Hunan, China.
Hu H; Reproductive and Genetic Hospital of CITIC-Xiangya, Changsha Hunan, China; Clinical Research Center For Reproduction and Genetics in Hunan Province, Changsha Hunan, China.
Wu X; National Engineering and Research Center of Human Stem Cells, Changsha Hunan, China.
Xie P; National Engineering and Research Center of Human Stem Cells, Changsha Hunan, China.
Lu C; Reproductive and Genetic Hospital of CITIC-Xiangya, Changsha Hunan, China; Clinical Research Center For Reproduction and Genetics in Hunan Province, Changsha Hunan, China; Institute of Reproduction and Stem Cell Engineering, School of Basic Medical Science, Central South University, Changsha Hunan, China; National Engineering and Research Center of Human Stem Cells, Changsha Hunan, China; HC Key Laboratory of Human Stem Cell and Reproductive Engineering (Central South University), Changsha Hunan, China.
Lu G; Reproductive and Genetic Hospital of CITIC-Xiangya, Changsha Hunan, China; Clinical Research Center For Reproduction and Genetics in Hunan Province, Changsha Hunan, China; Institute of Reproduction and Stem Cell Engineering, School of Basic Medical Science, Central South University, Changsha Hunan, China; National Engineering and Research Center of Human Stem Cells, Changsha Hunan, China; HC Key Laboratory of Human Stem Cell and Reproductive Engineering (Central South University), Changsha Hunan, China.
Lin G; Reproductive and Genetic Hospital of CITIC-Xiangya, Changsha Hunan, China; Clinical Research Center For Reproduction and Genetics in Hunan Province, Changsha Hunan, China; Institute of Reproduction and Stem Cell Engineering, School of Basic Medical Science, Central South University, Changsha Hunan, China; National Engineering and Research Center of Human Stem Cells, Changsha Hunan, China; HC Key Laboratory of Human Stem Cell and Reproductive Engineering (Central South University), Changsha Hunan, China.
Gong F; Reproductive and Genetic Hospital of CITIC-Xiangya, Changsha Hunan, China; Clinical Research Center For Reproduction and Genetics in Hunan Province, Changsha Hunan, China; Institute of Reproduction and Stem Cell Engineering, School of Basic Medical Science, Central South University, Changsha Hunan, China; National Engineering and Research Center of Human Stem Cells, Changsha Hunan, China; HC Key Laboratory of Human Stem Cell and Reproductive Engineering (Central South University), Changsha Hunan, China. Electronic address: .
Tan YQ; Reproductive and Genetic Hospital of CITIC-Xiangya, Changsha Hunan, China; Clinical Research Center For Reproduction and Genetics in Hunan Province, Changsha Hunan, China; Institute of Reproduction and Stem Cell Engineering, School of Basic Medical Science, Central South University, Changsha Hunan, China; HC Key Laboratory of Human Stem Cell and Reproductive Engineering (Central South University), Changsha Hunan, China. Electronic address: .
Pokaż więcej
Źródło:
Reproductive biomedicine online [Reprod Biomed Online] 2021 Jul; Vol. 43 (1), pp. 73-80. Date of Electronic Publication: 2021 Mar 17.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Chromosomes, Human, Pair 1*
Chromosomes, Human, X*
Preimplantation Diagnosis*
Translocation, Genetic*
Abnormalities, Multiple/*genetics
Female ; Heart Defects, Congenital/genetics ; Humans ; Infant, Newborn ; Neurodevelopmental Disorders/genetics ; Reinfection/genetics
Czasopismo naukowe
Tytuł:
Role of 1q21 in Multiple Myeloma: From Pathogenesis to Possible Therapeutic Targets.
Autorzy:
Burroughs Garcìa J; Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy.; Department of Medical-Veterinary Science, University of Parma, 43121 Parma, Italy.
Eufemiese RA; Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy.
Storti P; Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy.
Sammarelli G; Hematology, Azienda Ospedaliero-Universitaria di Parma, 43126 Parma, Italy.
Craviotto L; Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy.; Hematology, Azienda Ospedaliero-Universitaria di Parma, 43126 Parma, Italy.
Todaro G; Hematology, Azienda Ospedaliero-Universitaria di Parma, 43126 Parma, Italy.
Toscani D; Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy.
Marchica V; Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy.
Giuliani N; Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy.; Hematology, Azienda Ospedaliero-Universitaria di Parma, 43126 Parma, Italy.
Pokaż więcej
Źródło:
Cells [Cells] 2021 Jun 01; Vol. 10 (6). Date of Electronic Publication: 2021 Jun 01.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Chromosomes, Human, Pair 1*/genetics
Chromosomes, Human, Pair 1*/metabolism
Gene Amplification*
Multiple Myeloma*/genetics
Multiple Myeloma*/metabolism
Multiple Myeloma*/therapy
Neoplasm Proteins*/genetics
Neoplasm Proteins*/metabolism
Signal Transduction*
Humans
Czasopismo naukowe
Tytuł:
CBFB gene rearrangement due to a novel t(1;16) with deceptive morphology.
Autorzy:
Gupta A; Department of Hematopathology and Molecular Genetics, AMPATH, Hyderabad, Telangana, India.
Reddy KG; Manipal Super specialty Hospital, Vijaywada, Andhra Pradesh, India.
Pokaż więcej
Źródło:
International journal of laboratory hematology [Int J Lab Hematol] 2021 Jun; Vol. 43 (3), pp. e128-e129. Date of Electronic Publication: 2020 Dec 04.
Typ publikacji:
Letter
MeSH Terms:
Chromosomes, Human, Pair 1*
Chromosomes, Human, Pair 22*
Gene Rearrangement*
Phenotype*
Protein Biosynthesis*
Core Binding Factor beta Subunit/*genetics
Genetic Association Studies/methods ; Genetic Predisposition to Disease ; Humans
Opinia redakcyjna
Tytuł:
MiR-3130-5p is an intermediate modulator of 2q33 and influences the invasiveness of lung adenocarcinoma by targeting NDUFS1.
Autorzy:
Zhan J; Department of Pulmonary and Critical Care Medicine, The Third Xiangya Hospital, Central South University, Changsha, China.; Department of Oncology, Zhongshan Hospital, Xiamen University, Xiamen, China.
Sun S; Department of Pulmonary and Critical Care Medicine, The Third Xiangya Hospital, Central South University, Changsha, China.
Chen Y; Laboratory, Xiamen Cancer Center, The First Affiliated Hospital of Xiamen University, Xiamen, China.
Xu C; National Institute for Data Science in Health and Medicine, School of Medicine, Xiamen University, Xiamen, China.
Chen Q; National Institute for Data Science in Health and Medicine, School of Medicine, Xiamen University, Xiamen, China.
Li M; Department of Thoracic Surgery, Zhongshan Hospital, Xiamen University, Xiamen, China.
Pei Y; Central Laboratory, Zhongshan Hospital, Xiamen University, Xiamen, China.
Li Q; National Institute for Data Science in Health and Medicine, School of Medicine, Xiamen University, Xiamen, China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2021 Jun; Vol. 10 (11), pp. 3700-3714. Date of Electronic Publication: 2021 May 12.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Chromosomes, Human, Pair 1*
Adenocarcinoma of Lung/*genetics
Lung Neoplasms/*genetics
MicroRNAs/*metabolism
NADH Dehydrogenase/*metabolism
Quantitative Trait Loci/*genetics
Adenocarcinoma of Lung/pathology ; Animals ; Cell Line, Tumor ; Cell Movement ; Epithelial-Mesenchymal Transition/genetics ; Genes, Tumor Suppressor ; Genome-Wide Association Study ; Heterografts ; Humans ; Lung Neoplasms/pathology ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Neoplasm Invasiveness/genetics ; Phenotype ; Prognosis ; Tumor Suppressor Proteins/metabolism
Czasopismo naukowe
Tytuł:
Duplication 1q is highly correlated with poor prognosis in high hyperdiploid pediatric B-acute lymphoblastic leukemia.
Autorzy:
El Ashry MS; Clinical Pathology Department, National Cancer Institute, Cairo University, Cairo, Egypt.
Elsayed GM; Clinical Pathology Department, National Cancer Institute, Cairo University, Cairo, Egypt.
Madney Y; Pediatric Oncology Department, National Cancer Institute, Cairo University, Cairo, Egypt.
Arafah O; Pediatric Oncology Department, National Cancer Institute, Cairo University, Cairo, Egypt.
Allam RM; Biostatistics and Cancer Epidemiology Department, National Cancer Institute, Cairo University, Cairo, Egypt.
Rasekh EO; Clinical Pathology Department, National Cancer Institute, Cairo University, Cairo, Egypt.
Pokaż więcej
Źródło:
International journal of laboratory hematology [Int J Lab Hematol] 2021 Apr; Vol. 43 (2), pp. 235-243. Date of Electronic Publication: 2020 Oct 19.
Typ publikacji:
Journal Article
MeSH Terms:
Chromosome Duplication*
Chromosomes, Human, Pair 1*
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/*genetics
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/*mortality
Adolescent ; Biomarkers ; Child ; Child, Preschool ; Chromosome Aberrations ; Cytogenetic Analysis ; Egypt/epidemiology ; Female ; Humans ; Infant ; Infant, Newborn ; Male ; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/diagnosis ; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/epidemiology ; Prognosis ; Proportional Hazards Models ; Translocation, Genetic
Czasopismo naukowe
Tytuł:
A Scalable Computational Approach for Simulating Complexes of Multiple Chromosomes.
Autorzy:
Oliveira Junior AB; Center for Theoretical Biological Physics, Rice University, Houston, TX, USA; ICTP South American Institute for Fundamental Research, Instituto de Física Teórica, UNESP - 01140-070, São Paulo, SP, Brazil. Electronic address: .
Contessoto VG; Center for Theoretical Biological Physics, Rice University, Houston, TX, USA; Instituto de Biociências, Letras e Ciências Exatas, UNESP - Univ. Estadual Paulista, Departamento de Física, São José do Rio Preto, SP, Brazil. Electronic address: .
Mello MF; Center for Theoretical Biological Physics, Rice University, Houston, TX, USA; Chemical Engineering Department, Military Institute of Engineering, Rio de Janeiro, RJ, Brazil.
Onuchic JN; Center for Theoretical Biological Physics, Rice University, Houston, TX, USA; ICTP South American Institute for Fundamental Research, Instituto de Física Teórica, UNESP - 01140-070, São Paulo, SP, Brazil. Electronic address: .
Pokaż więcej
Źródło:
Journal of molecular biology [J Mol Biol] 2021 Mar 19; Vol. 433 (6), pp. 166700. Date of Electronic Publication: 2020 Nov 06.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Molecular Dynamics Simulation*
Software*
Chromatin/*chemistry
Chromosomes, Human, Pair 1/*chemistry
Chromosomes, Human, Pair 2/*chemistry
Chromosomes, Human, Pair 3/*chemistry
Chromosomes, Human, Pair 4/*chemistry
Animals ; Cell Line, Tumor ; Chromatin/metabolism ; Chromatin/ultrastructure ; Chromosomes, Human, Pair 1/metabolism ; Chromosomes, Human, Pair 1/ultrastructure ; Chromosomes, Human, Pair 2/metabolism ; Chromosomes, Human, Pair 2/ultrastructure ; Chromosomes, Human, Pair 3/metabolism ; Chromosomes, Human, Pair 3/ultrastructure ; Chromosomes, Human, Pair 4/metabolism ; Chromosomes, Human, Pair 4/ultrastructure ; Drosophila melanogaster/genetics ; Drosophila melanogaster/metabolism ; Humans ; Lymphocytes/cytology ; Lymphocytes/metabolism ; Saccharum/genetics ; Saccharum/metabolism ; Thermodynamics ; Triticum/genetics ; Triticum/metabolism
Czasopismo naukowe
Tytuł:
Genomic and epigenetic aberrations of chromosome 1p36.13 have prognostic implications in malignancies.
Autorzy:
Naderi A; Cancer Biology Program, University of Hawaii Cancer Center, 701 Ilalo Street, Honolulu, HI, 96813, USA. .; Queensland University of Technology, Gardens Point, Brisbane, Queensland, 4001, Australia. .
Pokaż więcej
Źródło:
Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology [Chromosome Res] 2020 Dec; Vol. 28 (3-4), pp. 307-330. Date of Electronic Publication: 2020 Aug 20.
Typ publikacji:
Journal Article
MeSH Terms:
Chromosome Aberrations*
Chromosomes, Human, Pair 1*
Epigenomics*/methods
Genomics*/methods
Neoplasms/*genetics
Neoplasms/*mortality
DNA Copy Number Variations ; DNA Methylation ; Epigenesis, Genetic ; Gene Expression Profiling ; Gene Expression Regulation, Neoplastic ; Genetic Association Studies/methods ; Genetic Predisposition to Disease ; Humans ; Kaplan-Meier Estimate ; Mutation ; Neoplasms/diagnosis ; Organ Specificity/genetics ; Prognosis
Czasopismo naukowe
Tytuł:
TERT promoter mutation confers favorable prognosis regardless of 1p/19q status in adult diffuse gliomas with IDH1/2 mutations.
Autorzy:
Arita H; Division of Brain Tumor Translational Research, National Cancer Center Research Institute, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. .; Department of Neurosurgery, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita-City, Osaka, 565-0871, Japan. .
Matsushita Y; Division of Brain Tumor Translational Research, National Cancer Center Research Institute, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.; Department of Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Machida R; Biostatistics Division, Center for Research Administration and Support, National Cancer Center, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Yamasaki K; Division of Brain Tumor Translational Research, National Cancer Center Research Institute, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.; Department of Pediatric Hematology and Oncology, Osaka City General Hospital, 2-13-22, Miyakojima-hondori, Miyakojima-ku, Osaka-City, Osaka, 534-0021, Japan.
Hata N; Department of Neurosurgery, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka-City, Fukuoka, 812-8582, Japan.
Ohno M; Department of Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Yamaguchi S; Department of Neurosurgery, Faculty of Medicine, Hokkaido University, North 15 West 7, Kita-ku, Sapporo-City, Hokkaido, 060-8638, Japan.
Sasayama T; Department of Neurosurgery, Kobe University Graduate School of Medicine, 7-5-2, Kusunoki-cho, Chuo-ku, Kobe-City, Hyogo, 650-0017, Japan.
Tanaka S; Department of Neurosurgery, Faculty of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
Higuchi F; Department of Neurosurgery, Dokkyo Medical University, 880, Kitakobayashi, Mibu-City, Tochigi, 321-0293, Japan.
Iuchi T; Division of Neurological Surgery, Chiba Cancer Center, 666-2 Nitonacho, Chuo-ku, Chiba-City, Chiba, 260-8717, Japan.
Saito K; Department of Neurosurgery, Kyorin University Faculty of Medicine, 6-20-2, Shinkawa, Mitaka-City, Tokyo, 181-8611, Japan.
Kanamori M; Department of Neurosurgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai-City, Miyagi, 980-8574, Japan.
Matsuda KI; Department of Neurosurgery, Faculty of Medicine, Yamagata University, 2-2, Iida-Nishi, Yamagata-City, Yamagata, 990-9585, Japan.
Miyake Y; Department of Neuro-Oncology/Neurosurgery, Saitama Medical University International Medical Center, 1397-1, Yamane, Hidaka-City, Saitama, 350-1298, Japan.; Department of Neurosurgery, Graduate School of Medicine, Yokohama City University, 3-9, Fukuura, Kanazawa-ku, Yokohama-City, Kanagawa, 236-0004, Japan.
Tamura K; Department of Neurosurgery, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan.
Tamai S; Department of Neurosurgery, Graduate School of Medical Science, Kanazawa University, 13-1, Takara-machi, Kanazawa-City, Ishikawa, 920-8641, Japan.
Nakamura T; Department of Neurosurgery, Graduate School of Medicine, Yokohama City University, 3-9, Fukuura, Kanazawa-ku, Yokohama-City, Kanagawa, 236-0004, Japan.
Uda T; Department of Neurosurgery, Osaka City University Graduate School of Medicine, 1-5-7, Asahi-machi, Abeno-ku, Osaka-City, Osaka, 545-8586, Japan.
Okita Y; Department of Neurosurgery, National Hospital Organization Osaka National Hospital, 2-1-14 Hoenzaka, Chuo-ku, Osaka-City, Osaka, 540-0006, Japan.; Department of Neurosurgery, Osaka International Cancer Institute, 3-1-69, Otemae, Chuo-ku, Osaka-City, Osaka, 541-8567, Japan.
Fukai J; Department of Neurological Surgery, Wakayama Medical University, 811-1, Kimiidera, Wakayama-City, Wakayama, 641-0012, Japan.
Sakamoto D; Department of Neurosurgery, Hyogo College of Medicine, 1-1 Mukogawa, Nishinomiya-City, Hyogo, 663-8501, Japan.
Hattori Y; Department of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama-City, Okayama, 700-8558, Japan.
Pareira ES; Department of Neurosurgery, Keio University School of Medicine, 35, Shinano-machi, Tokyo, Shinjuku-ku, 160-8582, Japan.
Hatae R; Department of Neurosurgery, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka-City, Fukuoka, 812-8582, Japan.
Ishi Y; Department of Neurosurgery, Faculty of Medicine, Hokkaido University, North 15 West 7, Kita-ku, Sapporo-City, Hokkaido, 060-8638, Japan.
Miyakita Y; Department of Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Tanaka K; Department of Neurosurgery, Kobe University Graduate School of Medicine, 7-5-2, Kusunoki-cho, Chuo-ku, Kobe-City, Hyogo, 650-0017, Japan.
Takayanagi S; Department of Neurosurgery, Faculty of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
Otani R; Department of Neurosurgery, Dokkyo Medical University, 880, Kitakobayashi, Mibu-City, Tochigi, 321-0293, Japan.; Department of Neurosurgery, Tokyo Metropolitan Komagome Hospital, 3-18-22, Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.
Sakaida T; Division of Neurological Surgery, Chiba Cancer Center, 666-2 Nitonacho, Chuo-ku, Chiba-City, Chiba, 260-8717, Japan.
Kobayashi K; Department of Neurosurgery, Kyorin University Faculty of Medicine, 6-20-2, Shinkawa, Mitaka-City, Tokyo, 181-8611, Japan.
Saito R; Department of Neurosurgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai-City, Miyagi, 980-8574, Japan.
Kurozumi K; Department of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama-City, Okayama, 700-8558, Japan.
Shofuda T; Department of Biomedical Research and Innovation Research, Institute for Clinical Research, National Hospital Organization Osaka National Hospital, 2-1-14, Hoenzaka, Chuo-ku, Osaka-City, Osaka, 540-0006, Japan.
Nonaka M; Department of Neurosurgery, National Hospital Organization Osaka National Hospital, 2-1-14 Hoenzaka, Chuo-ku, Osaka-City, Osaka, 540-0006, Japan.; Department of Neurosurgery, Kansai Medical University, 3-1, Shinmachi 2 Chome, Hirakata-City, Osaka, 573-1191, Japan.
Suzuki H; Department of Pathology and Laboratory Medicine, National Hospital Organization, Sendai Medical Center, 2-11-12, Miyagino, Miyagino-ku, Sendai-City, Miyagi, 983-8520, Japan.
Shibuya M; Central Clinical Laboratory, Hachioji Medical Center, Tokyo Medical University, 1163, Tatemachi, Hachioji-City, Tokyo, 193-0998, Japan.
Komori T; Department of Laboratory Medicine and Pathology (Neuropathology), Tokyo Metropolitan Neurological Hospital, 2-6-1 Musashidai, Fuchu, Tokyo, 183-0042, Japan.
Sasaki H; Department of Neurosurgery, Keio University School of Medicine, 35, Shinano-machi, Tokyo, Shinjuku-ku, 160-8582, Japan.
Mizoguchi M; Department of Neurosurgery, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka-City, Fukuoka, 812-8582, Japan.
Kishima H; Department of Neurosurgery, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita-City, Osaka, 565-0871, Japan.
Nakada M; Department of Neurosurgery, Graduate School of Medical Science, Kanazawa University, 13-1, Takara-machi, Kanazawa-City, Ishikawa, 920-8641, Japan.
Sonoda Y; Department of Neurosurgery, Faculty of Medicine, Yamagata University, 2-2, Iida-Nishi, Yamagata-City, Yamagata, 990-9585, Japan.
Tominaga T; Department of Neurosurgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai-City, Miyagi, 980-8574, Japan.
Nagane M; Department of Neurosurgery, Kyorin University Faculty of Medicine, 6-20-2, Shinkawa, Mitaka-City, Tokyo, 181-8611, Japan.
Nishikawa R; Department of Neuro-Oncology/Neurosurgery, Saitama Medical University International Medical Center, 1397-1, Yamane, Hidaka-City, Saitama, 350-1298, Japan.
Kanemura Y; Department of Neurosurgery, National Hospital Organization Osaka National Hospital, 2-1-14 Hoenzaka, Chuo-ku, Osaka-City, Osaka, 540-0006, Japan.; Department of Biomedical Research and Innovation Research, Institute for Clinical Research, National Hospital Organization Osaka National Hospital, 2-1-14, Hoenzaka, Chuo-ku, Osaka-City, Osaka, 540-0006, Japan.
Kuchiba A; Biostatistics Division, Center for Research Administration and Support, National Cancer Center, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Narita Y; Department of Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Ichimura K; Division of Brain Tumor Translational Research, National Cancer Center Research Institute, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. .
Pokaż więcej
Źródło:
Acta neuropathologica communications [Acta Neuropathol Commun] 2020 Nov 23; Vol. 8 (1), pp. 201. Date of Electronic Publication: 2020 Nov 23.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Chromosome Deletion*
Chromosomes, Human, Pair 1*
Chromosomes, Human, Pair 19*
Brain Neoplasms/*genetics
Glioma/*genetics
Promoter Regions, Genetic/*genetics
Telomerase/*genetics
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Astrocytoma/genetics ; Astrocytoma/pathology ; Astrocytoma/therapy ; Brain Neoplasms/pathology ; Brain Neoplasms/therapy ; Female ; Glioblastoma/genetics ; Glioblastoma/pathology ; Glioblastoma/therapy ; Glioma/pathology ; Glioma/therapy ; Humans ; Isocitrate Dehydrogenase/genetics ; Karnofsky Performance Status ; Male ; Middle Aged ; Multivariate Analysis ; Mutation ; Neoplasm Grading ; Neurosurgical Procedures ; Oligodendroglioma/genetics ; Oligodendroglioma/pathology ; Oligodendroglioma/therapy ; Prognosis ; Proportional Hazards Models ; Radiotherapy, Adjuvant ; Retrospective Studies ; Survival Rate ; Young Adult
Czasopismo naukowe
Tytuł:
Gain of 1q21 is an adverse prognostic factor for multiple myeloma patients treated by autologous stem cell transplantation: A multicenter study in China.
Autorzy:
Gao W; Department of Hematology, Myeloma Research Center of Beijing, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Jian Y; Department of Hematology, Myeloma Research Center of Beijing, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Du J; Department of Hematology, The Myeloma & Lymphoma Center, Changzheng Hospital, The Second Military Medical University, Shanghai, China.
Li X; Department of Hematology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Zhou H; Department of Hematology, Myeloma Research Center of Beijing, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Zhang Z; Department of Hematology, Myeloma Research Center of Beijing, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Yang G; Department of Hematology, Myeloma Research Center of Beijing, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Wang G; Department of Hematology, Myeloma Research Center of Beijing, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Tian Y; Department of Hematology, Myeloma Research Center of Beijing, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Li Y; Department of Hematology, Myeloma Research Center of Beijing, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Wu Y; Department of Hematology, Myeloma Research Center of Beijing, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Fu W; Department of Hematology, The Myeloma & Lymphoma Center, Changzheng Hospital, The Second Military Medical University, Shanghai, China.
Li J; Department of Hematology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Chen W; Department of Hematology, Myeloma Research Center of Beijing, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2020 Nov; Vol. 9 (21), pp. 7819-7829. Date of Electronic Publication: 2020 Sep 02.
Typ publikacji:
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Chromosome Aberrations*
Chromosomes, Human, Pair 1*
Multiple Myeloma/*genetics
Multiple Myeloma/*surgery
Stem Cell Transplantation/*adverse effects
Adult ; Aged ; China ; Female ; Humans ; In Situ Hybridization, Fluorescence ; Male ; Middle Aged ; Multiple Myeloma/diagnosis ; Multiple Myeloma/mortality ; Progression-Free Survival ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Time Factors ; Transplantation, Autologous/adverse effects ; Young Adult
Czasopismo naukowe
Tytuł:
Acute megakaryoblastic leukaemia with t(1;22)(p13·3;q13·1)/RBM15-MKL1 in an adult patient following a non-mediastinal germ cell tumour.
Autorzy:
Saito Y; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.; Department of Pathology, National Cancer Center Hospital, Tokyo, Japan.
Makita S; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
Chinen S; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
Kito M; Department of Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan.
Fujino T; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
Ida H; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
Hosoba R; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
Tanaka T; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
Fukuhara S; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
Munakata W; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.; Rare Cancer Center, National Cancer Center Hospital, Tokyo, Japan.
Suzuki T; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.; Rare Cancer Center, National Cancer Center Hospital, Tokyo, Japan.
Maruyama D; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
Miyagi-Maeshima A; Department of Pathology, National Cancer Center Hospital, Tokyo, Japan.
Matsushita H; Department of Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan.
Izutsu K; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.; Rare Cancer Center, National Cancer Center Hospital, Tokyo, Japan.
Pokaż więcej
Źródło:
British journal of haematology [Br J Haematol] 2020 Sep; Vol. 190 (6), pp. e329-e332. Date of Electronic Publication: 2020 Jun 23.
Typ publikacji:
Case Reports; Letter
MeSH Terms:
Chromosomes, Human, Pair 1*/genetics
Chromosomes, Human, Pair 1*/metabolism
Chromosomes, Human, Pair 22*/genetics
Chromosomes, Human, Pair 22*/metabolism
Leukemia, Megakaryoblastic, Acute*/genetics
Leukemia, Megakaryoblastic, Acute*/metabolism
Leukemia, Megakaryoblastic, Acute*/pathology
Neoplasms, Germ Cell and Embryonal*/genetics
Neoplasms, Germ Cell and Embryonal*/metabolism
Neoplasms, Germ Cell and Embryonal*/pathology
Neoplasms, Second Primary*/genetics
Neoplasms, Second Primary*/metabolism
Neoplasms, Second Primary*/pathology
Oncogene Proteins, Fusion*/genetics
Oncogene Proteins, Fusion*/metabolism
Retroperitoneal Neoplasms*/genetics
Retroperitoneal Neoplasms*/metabolism
Retroperitoneal Neoplasms*/pathology
Translocation, Genetic*
Adult ; Humans ; Male
Raport
Tytuł:
A retrospective analysis of recurrent pediatric ependymoma reveals extremely poor survival and ineffectiveness of current treatments across central nervous system locations and molecular subgroups.
Autorzy:
Ritzmann TA; Children's Brain Tumor Research Centre, School of Medicine, University of Nottingham, Nottingham, UK.
Rogers HA; Children's Brain Tumor Research Centre, School of Medicine, University of Nottingham, Nottingham, UK.
Paine SML; Department of Neuropathology, Nottingham University Hospital, Nottingham, UK.
Storer LCD; Children's Brain Tumor Research Centre, School of Medicine, University of Nottingham, Nottingham, UK.
Jacques TS; Developmental Biology and Cancer Programme, UCL GOS Institute of Child Health and Department of Histopathology, Great Ormond Street Hospital for Children NHS Trust, London, UK.
Chapman RJ; Children's Brain Tumor Research Centre, School of Medicine, University of Nottingham, Nottingham, UK.
Ellison D; Department of Pathology, St Jude Children's Hospital, Memphis, Tennessee.
Donson AM; Department of Pediatrics, University of Colorado, Denver, Aurora, Colorado.
Foreman NK; Department of Pediatrics, University of Colorado, Denver, Aurora, Colorado.
Grundy RG; Children's Brain Tumor Research Centre, School of Medicine, University of Nottingham, Nottingham, UK.
Pokaż więcej
Źródło:
Pediatric blood & cancer [Pediatr Blood Cancer] 2020 Sep; Vol. 67 (9), pp. e28426. Date of Electronic Publication: 2020 Jul 02.
Typ publikacji:
Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Brain Neoplasms*/genetics
Brain Neoplasms*/metabolism
Brain Neoplasms*/mortality
Brain Neoplasms*/therapy
Chromosomes, Human, Pair 1*/genetics
Chromosomes, Human, Pair 1*/metabolism
DNA Methylation*
DNA, Neoplasm*/genetics
DNA, Neoplasm*/metabolism
Ependymoma*/genetics
Ependymoma*/metabolism
Ependymoma*/mortality
Ependymoma*/therapy
Neoplasm Recurrence, Local*/genetics
Neoplasm Recurrence, Local*/metabolism
Neoplasm Recurrence, Local*/mortality
Neoplasm Recurrence, Local*/therapy
Adolescent ; Child ; Child, Preschool ; Female ; Humans ; Infant ; Infant, Newborn ; Male ; Retrospective Studies ; Risk Factors
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies